No Data
ShuYu Civilian Pharmacy Corp., Ltd. (SZSE:301017) Soars 26% But It's A Story Of Risk Vs Reward
Shuyu Pingmin (301017.SZ): It is planned to postpone the "Shuyu Pingmin Modern Logistics Project (Phase II)" until December 31, 2026.
On November 27, Glonghui reported that Shuyupingmin (301017.SZ) announced that the company will hold the third session of the board of directors' thirty-eighth meeting and the third session of the supervisory board's twenty-sixth meeting on November 27, 2024, to review and approve the proposal on the extension of some fundraising projects for convertible bonds. Considering the actual implementation progress of the fundraising projects for convertible bonds (hereinafter referred to as "convertible bond fundraising projects"), the company will extend part of the fundraising projects for convertible bonds without changes in the main body of the convertible bond fundraising projects, the use of raised funds, and the scale of investment, with the project of "Shuyuping."
Shu Yu Civilian (301017.SZ): Ali Health has collectively reduced its shareholding by 1.15%.
On November 5th, Gelonhui announced that recently, the company has received a notification letter from shareholder ali health regarding the reduction of shareholding by more than 1%, from November 1, 2024 to November 4, 2024. Ali health has reduced its holdings by 4,000,000 shares through centralized competitive trading, representing a reduction percentage of 0.99%; and by 640,000 shares through block trading, representing a reduction percentage of 0.16%. The total reduced shares amount to 4,640,000 shares, with a total reduction percentage of 1.15%.
Shuyu Pingmin: Report for the third quarter of 2024
Shu Yu Pingmin (301017.SZ) released its performance for the first three quarters, with a net loss of 13.192 million yuan.
Shu Yu Pingmin (301017.SZ) released the third quarter report for 2024, with the company's revenue for the first three quarters at 7...
Shu Yu Ping Min (301017.SZ): a net loss of 13.192 million yuan in the first three quarters.
GeLongHui announced its third-quarter report for 2024 on October 29th. The company achieved revenue of 7.078 billion yuan in the first three quarters, an 8.32% year-on-year growth; the net income attributable to shareholders of the listed company was -13.192 million yuan; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was -15.6147 million yuan; the basic earnings per share was -0.03 yuan.
ShuYu Civilian Pharmacy Corp., Ltd. (SZSE:301017) Delivered A Better ROE Than Its IndustryNo Data
No Data
